Exogenous Modulation of Retinoic Acid Signaling Affects Adult RGC Survival in the Frog Visual System after Optic Nerve Injury.
After lesions to the mammalian optic nerve, the great majority of retinal ganglion cells (RGCs) die before their axons have even had a chance to regenerate. Frog RGCs, on the other hand, suffer only an approximately 50% cell loss, and we have previously investigated the mechanisms by which the application of growth factors can increase their survival rate. Retinoic acid (RA) is a vitamin A-derived lipophilic molecule that plays major roles during development of the nervous system. The RA signaling pathway is also present in parts of the adult nervous system, and components of it are upregulated after injury in peripheral nerves but not in the CNS. Here we investigate whether RA signaling affects long-term RGC survival at 6 weeks after axotomy. Intraocular injection of all-trans retinoic acid (ATRA), the retinoic acid receptor (RAR) type-α agonist AM80, the RARβ agonist CD2314, or the RARγ agonist CD1530, returned axotomized RGC numbers to almost normal levels. On the other hand, inhibition of RA synthesis with disulfiram, or of RAR receptors with the pan-RAR antagonist Ro-41-5253, or the RARβ antagonist LE135E, greatly reduced the survival of the axotomized neurons. Axotomy elicited a strong activation of the MAPK, STAT3 and AKT pathways; this activation was prevented by disulfiram or by RAR antagonists. Finally, addition of exogenous ATRA stimulated the activation of the first two of these pathways. Future experiments will investigate whether these strong survival-promoting effects of RA are mediated via the upregulation of neurotrophins.
Department of Anatomy and Neurobiology, School of Medicine, University of Puerto Rico, San Juan, PR, United States of America.|Institute of Neurobiology, University of Puerto Rico Medical Sciences Campus, San Juan, PR, United States of America.
Mildred V
MV
Duprey-Díaz
Institute of Neurobiology, University of Puerto Rico Medical Sciences Campus, San Juan, PR, United States of America.
Jonathan M
JM
Blagburn
Department of Anatomy and Neurobiology, School of Medicine, University of Puerto Rico, San Juan, PR, United States of America.|Institute of Neurobiology, University of Puerto Rico Medical Sciences Campus, San Juan, PR, United States of America.
Rosa E
RE
Blanco
D000818:Animals; D001001:Anura; D001565:Benzoates / Q000494:pharmacology; D002839:Chromans / Q000494:pharmacology; D009284:Naphthols / Q000494:pharmacology; D009416:Nerve Regeneration / Q000187:drug effects*; D009900:Optic Nerve / Q000187:drug effects*; D020221:Optic Nerve Injuries / Q000378:metabolism*; D018168:Receptors, Retinoic Acid / Q000819:agonists / Q000037:antagonists & inhibitors / Q000378:metabolism; D012165:Retinal Ganglion Cells / Q000187:drug effects / Q000378:metabolism; D013764:Tetrahydronaphthalenes / Q000494:pharmacology; D014212:Tretinoin / Q000378:metabolism*
C000591478:4-(6-hydroxy-7-tricyclo(3.3.1.13,7)dec-1-yl-2-naphthalenyl)benzoic acid; D001565:Benzoates; D002839:Chromans; D009284:Naphthols; D018168:Receptors, Retinoic Acid; D013764:Tetrahydronaphthalenes; C061133:tamibarotene; C084904:Ro 41-5253; D014212:Tretinoin